NCT02546869 A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting Status WITHDRAWN Phase PHASE3
NCT02546700 A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2
NCT02545868 A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT02545283 A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) Status TERMINATED Phase PHASE3
NCT02542436 Avastin (Bevacizumab) in the Treatment of Metastatic Colorectal Cancer in Normal Clinical Use in the UK Population Status WITHDRAWN Phase N/A
NCT02541604 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT02540213 Observational Study of MIRCERA in Users of Self-Application and Multidose Systems Status COMPLETED Phase N/A
NCT02538562 Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea Status COMPLETED Phase N/A
NCT02538107 An Observational Study of Methoxy Polyethylene Glycol-epoetin Beta in Participants With a Kidney Transplant Status COMPLETED Phase N/A
NCT02537691 Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers Status COMPLETED Phase PHASE4
NCT02536664 Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants Status COMPLETED Phase N/A
NCT02535026 An Observational Study on Human Epidermal Growth Factor Receptor (HER) 2 Status of Breast Invasive Carcinoma in Latin American Participants Status COMPLETED Phase N/A
NCT02534311 A Phase IV Study to Evaluate the Effect of Subcutaneous (SC) Tocilizumab Administered to Participants With Rheumatoid Arthritis (RA) Assessed Using Disease Activity Score (DAS28) Status COMPLETED Phase N/A
NCT02534207 Basmisanil Positron Emission Tomography Study in Japanese Volunteers Status COMPLETED Phase PHASE1
NCT02533401 A Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL) Status COMPLETED Phase PHASE2
NCT02528747 A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate Status COMPLETED Phase N/A
NCT02525484 A Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT02521610 A Multiple Ascending-Dose Study of RG7625 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02515669 Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD Status TERMINATED Phase PHASE1/PHASE2
NCT02515279 An Observational Study of Peginterferon Alfa-2a Plus Ribavirin for Hepatitis C Virus (HCV) Infection in Austria Status COMPLETED Phase N/A